Company financials

Agilent Technologies

Health Care Life Sciences Tools & Services Santa Clara, California Last filing Dec 22, 2025 · FY2025

                    Revenue
                    FY2025
                
$6.9B
                    3y CAGR +0.5%
                    
                    P17
                    
                    +6.7%
                    
                    Net income
                    FY2025
                
$1.3B
                    Net margin +18.8%
                    
                    P77
                    
                    +1.1%
                    
                    Total assets
                    FY2025
                
$12.7B
                    ROA +10.2%
                    
                    P72
                    
                    +7.4%
                    
                    Operating cash flow
                    FY2025
                
$1.6B
                    FCF margin +16.6%
                    
                    P55
                    
                    -11.0%

20 yrs · FY2006–FY2025 9 filed · 0 derived · 0 blank

1Y 3Y 5Y 10Y

Dollars % of revenue % of assets YoY % CAGR

Each cell as a share of that year’s revenue.

Balance Sheet

Assets, liabilities, and equity

31 accounts · 5 years

Total assets $12.7B

Total liabilities $6.0B

Shareholders equity $6.7B

Account	2025	2024	2023	2022	2021
Assets
Cash and Cash Equivalents	25.7%	20.4%	23.3%	15.4%	23.5%
Short Term Investments	0.0%	0.0%	0.0%	—	—
Accounts Receivable	21.4%	20.3%	18.9%	20.5%	18.5%
Inventory	14.8%	14.9%	15.1%	—	—
Prepaid Expenses	4.2%	5.1%	4.0%	—	—
Other Current Assets	4.2%	5.1%	4.0%	—	—
Total Current Assets	66.1%	60.8%	61.3%	55.2%	60.1%
Property,Plant and Equipment	29.1%	27.3%	18.6%	16.1%	15.0%
Operating Lease Assets	2.6%	2.7%	2.3%	2.2%	2.8%
Goodwill	64.4%	68.8%	58.0%	57.7%	62.9%
Intangible Assets	6.4%	8.4%	7.0%	—	—
Long Term Investments	1.9%	2.7%	2.4%	2.8%	2.9%
Other Noncurrent Assets	15.2%	14.0%	10.4%	10.0%	13.0%
Total Assets	183.2%	182.0%	157.5%	153.8%	169.4%
Liabilities
Accounts Payable	8.2%	8.3%	6.1%	8.5%	7.1%
Accrued Liabilities	6.4%	8.0%	6.5%	9.2%	10.6%
Deferred Revenue	9.0%	8.4%	7.4%	—	—
Current Portion of Long Term Debt	4.4%	0.7%	0.0%	—	—
Total Current Liabilities	33.8%	29.1%	23.5%	27.2%	27.0%
Long Term Debt	43.9%	51.4%	40.0%	39.9%	43.2%
Deferred Revenue Noncurrent	9.0%	8.4%	7.4%	—	—
Other Noncurrent Liabilities	6.7%	8.9%	7.0%	7.8%	10.4%
Total Liabilities	86.2%	91.4%	72.0%	76.3%	84.1%
Equity
Preferred Stock	0.0%	0.0%	0.0%	0.0%	0.0%
Common Stock	0.0%	0.0%	0.0%	0.0%	0.0%
Additional Paid In Capital	80.2%	83.7%	78.8%	77.8%	84.2%
Retained Earnings	20.0%	11.5%	11.4%	—	—
Treasury Stock	0.0%	0.0%	0.0%	—	—
Accumulated Other Comprehensive Income	-3.3%	-4.7%	-4.8%	—	—
Total Stockholders Equity	97.0%	90.6%	85.5%	77.5%	85.3%
Total Liabilitiesand Equity	183.2%	182.0%	157.5%	153.8%	169.4%

Income Statement

Revenue, expense, and profitability

20 accounts · 5 years

Revenue $6.9B

Operating income $1.5B

Net income $1.3B

Account	2025	2024	2023	2022	2021
IncomeStatement
Revenues Total Revenue	100.0%	100.0%	100.0%	—	—
Expenses Cost of Revenue	47.6%	45.7%	49.3%	—	—
Expenses Research and Development	6.5%	7.4%	7.0%	—	—
Expenses Selling,General and Administrative	24.6%	24.1%	23.9%	—	—
Expenses Depreciation and Amortization	4.1%	3.9%	4.0%	—	—
Expenses Share Based Compensation	1.8%	2.0%	1.6%	—	—
Expenses Restructuring and Asset Impairment	1.2%	1.2%	0.7%	—	—
Expenses Operating Expenses	78.7%	77.1%	80.2%	—	—
Other Income Expense Operating Income	21.3%	22.9%	19.8%	—	—
Other Income Expense Interest Income	0.9%	1.2%	0.7%	0.1%	0.0%
Other Income Expense Interest Expense	1.6%	1.5%	1.4%	1.2%	1.3%
Other Income Expense Other Income/expense	0.1%	0.8%	0.5%	—	—
Other Income Expense Income Before Tax	20.7%	23.4%	19.6%	—	—
Income Tax Income Tax Expense	1.9%	3.6%	1.4%	—	—
net Income net Income	18.8%	19.8%	18.1%	—	—
net Income Comprehensive Income	19.9%	20.1%	18.4%	—	—
Earnings Per Share Basic Eps	0.0%	0.0%	0.0%	—	—
Earnings Per Share Diluted Eps	0.0%	0.0%	0.0%	—	—
Earnings Per Share Weighted Average Shares Basic	4.1%	4.5%	4.3%	—	—
Earnings Per Share Weighted Average Shares Diluted	4.1%	4.5%	4.3%	—	—

Cash Flow Statement

Operating, investing, and financing flows

22 accounts · 5 years

Operating cash flow $1.6B

Investing cash flow $-394.0M

Financing cash flow $-715.0M

Account	2025	2024	2023	2022	2021
CashFlow
Operating Activities net Income	18.8%	19.8%	18.1%	—	—
Operating Activities Depreciation and Amortization	4.1%	3.9%	4.0%	4.6%	5.1%
Operating Activities Stock Based Compensation	1.8%	2.0%	1.6%	—	—
Operating Activities Deferred Income Taxes	-1.9%	-1.0%	-0.8%	0.1%	0.2%
Operating Activities Changes In Operating Assets and Liabilities	12.0%	8.0%	2.8%	0.1%	0.2%
Operating Activities net Cash From Operating Activities	22.4%	26.9%	25.9%	19.2%	23.5%
Investing Activities Capital Expenditures	5.9%	5.8%	4.4%	—	—
Investing Activities Business Acquisitions	-0.1%	13.2%	0.7%	—	—
Investing Activities Purchases of Investments	0.0%	0.1%	0.1%	—	—
Investing Activities net Cash From Investing Activities	-5.7%	-19.3%	-4.5%	-4.9%	-11.9%
Financing Activities Proceeds From Debt	0.1%	18.4%	0.0%	—	—
Financing Activities Repayment of Debt	0.0%	9.2%	0.0%	—	—
Financing Activities Repurchase of Common Stock	6.1%	17.7%	8.4%	—	—
Financing Activities Dividends Paid	4.1%	4.2%	3.9%	—	—
Financing Activities Proceeds From Stock Issuance	1.0%	1.2%	1.0%	—	—
Financing Activities Tax Withholding On Stock Based Compensation	0.4%	0.5%	0.8%	—	—
Financing Activities Other Financing Activities	0.0%	0.0%	0.0%	—	—
Financing Activities net Cash From Financing Activities	-10.3%	-11.6%	-13.6%	-20.0%	-11.0%
Cash Reconciliation Effect of Exchange Rate On Cash	0.1%	-0.0%	0.1%	—	—
Cash Reconciliation net Change In Cash	6.6%	-4.0%	7.9%	—	—
Cash Reconciliation Cash At Beginning of Period	25.8%	20.5%	23.3%	—	—
Cash Reconciliation Cash At End of Period	25.8%	20.5%	23.3%	—	—

Key Ratios

Margins, returns, liquidity, leverage, efficiency

Computed at import · 5 years

Ratio	2025	2024	2023	2022	2021
Profitability
Gross margin	+52.4%	+54.3%	+50.7%	+54.4%	+53.9%
Operating margin	+21.3%	+22.9%	+19.8%	+23.6%	+21.3%
Net margin	+18.8%	+19.8%	+18.1%	—	+19.1%
FCF margin	+16.6%	+21.1%	+21.6%	+14.9%	+20.5%
Growth
Revenue CAGR (3y)	+0.5%	+1.0%	+8.6%	+9.9%	+8.7%
Returns
ROE	+19.3%	+21.9%	+21.2%	—	+22.5%
ROA	+10.2%	+10.9%	+11.5%	—	+11.3%
ROIC	+16.2%	+15.8%	+17.9%	+23.0%	+20.3%
Liquidity
Current ratio	1.96x	2.09x	2.61x	2.03x	2.22x
Quick ratio	1.40x	1.40x	1.80x	1.32x	1.56x
Leverage
D/E	0.89x	1.01x	0.84x	0.99x	0.99x
Interest coverage	13.21x	15.50x	14.21x	19.26x	16.63x
Efficiency
Asset turnover	0.55x	0.55x	0.63x	0.65x	0.59x
Cash conversion cycle	+128d	+127d	+135d	+128d	+116d

Valuation

Price against fundamentals

A $115 · 2026-04-02 · 166d old · FY2025

Market cap $32.9B

P/E 25.26x

P/S 4.74x

P/B 4.88x

EV $34.5B

EV/EBITDA 19.51x

FCF yield +3.5%

Dividend yield +0.9%

Notes

Your annotations

Not watched